2021
DOI: 10.1016/j.adro.2021.100687
|View full text |Cite
|
Sign up to set email alerts
|

Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 47 publications
0
5
0
Order By: Relevance
“…Treatment failure can occur as late as 10 years after SRS, which is one reason for encouraging continued radiographic surveillance (47,48). In the current report and elsewhere, SRS treatment failure was defined as those patients requiring further therapeutic intervention because of continued tumor growth and progressive symptoms at least 2 years after the date of treatment or because of growth without progressive symptoms after 5 years (49–51). The authors do acknowledge that there is no clear consensus on the criteria for the diagnosis of SRS treatment failure.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment failure can occur as late as 10 years after SRS, which is one reason for encouraging continued radiographic surveillance (47,48). In the current report and elsewhere, SRS treatment failure was defined as those patients requiring further therapeutic intervention because of continued tumor growth and progressive symptoms at least 2 years after the date of treatment or because of growth without progressive symptoms after 5 years (49–51). The authors do acknowledge that there is no clear consensus on the criteria for the diagnosis of SRS treatment failure.…”
Section: Discussionmentioning
confidence: 99%
“…The predictors that have been identified include radiation dose, tumor volume, appearance in MR images (solid vs cystic), and radiomic features. [1][2][3][6][7][8] Nonetheless, these results have been inconclusive and contradictory. In this study, our results revealed that some radiological features were associated with pseudoprogression/ fluctuation after GKRS and could be used as predictors of pseudoprogression.…”
Section: Discussionmentioning
confidence: 99%
“…Potential predictors include radiation dose, tumor volume, appearance in magnetic resonance (MR) images (solid vs cystic VS), and radiomic features. [1][2][3][6][7][8] However, these results have been inconclusive and contradictory. Moreover, most previous studies focused on the radiological features of entire tumor.…”
mentioning
confidence: 99%
“…As shown in Figure 6(d), we also observe that pseudo-progression occurs after tumor transient reduction with the initial value (u 0 , x 0 , y 0 )= (0.4, 0.05, 0.05). Indeed, we find the clinical case of this in [39]. In section 4, mouse data are used to fit model parameters, but there may be more complex situations in human body.…”
Section: Existence Stability and Bifurcation Analysis Of Positive Equ...mentioning
confidence: 99%